Investing in Cannabis: Should You Go Green?

Investing in Cannabis: Should You Go Green?

In 2012, Colorado and Washington were the first states to approve the recreational use of marijuana. Since then, cannabis has been legalized recreationally in eleven states and medically in thirty. About a year ago, Canada became the largest country to legalize cannabis completely. Colorado has now generated more than $1 billion in state revenue since 2014, with almost $7 billion in total sales.

Voice of Blockchain to Offer Insights for all Members of the Blockchain Ecosystem

Voice of Blockchain to Offer Insights for all Members of the Blockchain Ecosystem

Located in the heart of Chicago – a city with a strong legacy as a world leader in using technology to evolve equity and futures markets – the Second Annual Voice of Blockchain will aim to vertically connect representatives from all levels of the blockchain industry, creating a unique learning experience that will be second to none.

Widely recognized as the largest blockchain and digital asset event in the Midwest, Voice of Blockchain will bring 1,000 attendees, 200 speakers and 20 exhibitors together at the prominent Venue SIX10 in Chicago. The venue boasts stunning views of Lake Michigan and the city skyline, and the conference is said to “pull in the entire Chicago blockchain community.” According to one attendee (http://nnw.fm/H9AfI), “If you want your voice to be heard in Chicago, this is the event to attend.”

Thanks to the combination of three events in one conference, Voice of Blockchain offers the opportunity for guests to network with individuals from a number of fields, including corporate and enterprise, digital assets and markets, and impact and innovation. This design resonates with the event’s overall goal – to connect all levels of the blockchain ecosystem.

Representatives from the enterprise, investment and regulatory institutions will lend corporate and governmental insight. Meanwhile, speakers from startups, media, academia and specialized resources will speak about marketing, public relations, growth and the latest in professorial research. Finally, influencers representing blogs and podcasts will share their knowledge of popular culture.

This well-rounded and carefully curated lineup aims to provide the most valuable conversations among all blockchain events. Conference-goers will rub shoulders with CEOs, economists, reporters, startup founders, human rights leaders, Youtubers and more.

Voice of Blockchain will run Monday, September 30, and Tuesday, October 1, 2019. Presentations start each morning at 8:00 a.m., and events run back-to-back throughout the day, with multiple events happening on all three stages. Conference highlights will include keynote addresses, panels, fireside chats and presentations.

For more information, visit the event’s website at www.VoiceofBlockchain.com

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

 

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

 

Mortgage Rates Jump

Mortgage Rates Jump

MCLEAN, Va., Sept. 19, 2019 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) rate averaged 3.73 percent. This week’s 30-year fixed mortgage rate increase is the largest week-to-week uptick since October 2018.

Sam Khater, Freddie Mac’s Chief Economist says, “Despite the rise in mortgage rates, economic data improved this week – particularly housing activity, which gained momentum with a noticeable rise in purchase demand and new construction. Homebuyers flocked to lenders with purchase applications, which were up fifteen percent from a year ago and residential construction permits increased twelve percent from a year ago to 1.4 million, the highest level in twelve years. While there was initially a slow response to the overall lower mortgage rate environment this year, it is clear that the housing market is finally improving due to the strong labor market and low mortgage rates.”

News Facts

  • 30-year fixed-rate mortgage averaged 3.73 percent with an average 0.5 point for the week ending September 19, 2019, up from last week when it averaged 3.56 percent. A year ago at this time, the 30-year FRM averaged 4.65 percent. 
  • 15-year fixed-rate mortgage averaged 3.21 percent with an average 0.5 point, up from last week when it averaged 3.09 percent. A year ago at this time, the 15-year FRM averaged 4.11 percent. 
  • 5-year Treasury-indexed hybrid adjustable-rate
    mortgage
     (ARM) averaged 3.49 percent with an average 0.4 point, up from last week when it averaged 3.36 percent. A year ago at this time, the 5-year ARM averaged 3.92 percent.

Average commitment rates should be reported along with average fees and points to reflect the total upfront cost of obtaining the mortgage. Visit the following link for the Definitions. Borrowers may still pay closing costs which are not included in the survey.

Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, investors and taxpayers. Learn more at FreddieMac.com, Twitter 
@FreddieMac and Freddie Mac’s blog FreddieMac.com/blog.

MEDIA CONTACT: 
Angela Waugaman
703-714-4829
Angela_Waugaman@FreddieMac.com

Scotiabank supports young Canadians with a $500,000 donation to the Terry Fox PROFYLE program

Scotiabank supports young Canadians with a $500,000 donation to the Terry Fox PROFYLE program

Canada NewsWire

TORONTO, Sept. 18, 2019

TORONTO, Sept. 18, 2019 /CNW/ – Scotiabank has donated $500,000 to the Terry Fox Foundation PROFYLE program, to help give young Canadians with hard-to-treat cancers access to potentially life-saving treatment.

Scotiabank (CNW Group/Scotiabank) The Terry Fox PROFYLE – short for PRecision Oncology For Young peopLE – is a unique program that uses precision medicine to treat qualifying babies, children and young adults across Canada. Through this project, patients who are out of treatment options have their tumours and genomes profiled and analyzed, and are connected to a network of top cancer researchers. This helps to identify drugs that might work for these patients based on the molecular profile of their tumours.

“Young people are our future leaders and Scotiabank’s goal is to help ensure that they have the necessary resources they need to support their success,” says Karen Soos, Director of Philanthropy at Scotiabank. “We are investing in Terry Fox PROFYLE to help young people thrive and reach their infinite potential through improved access to the best healthcare. This program gives another chance to young people who have been told there are no more treatment options.”

Scotiabank and its employees are focused on enriching the lives of young people in the community. Through this donation, Scotiabank hopes to give more young people resources to help them grow into healthy, contributing adults. The Terry Fox PROFYLE program began in 2017 and today more than 300 children enrolled.

“We are so grateful for the support and commitment of Scotiabank in helping us to find new treatments and more answers for the 20% of children, adolescents, and young adults with hard-to-treat cancers,” says Heather Scott, Director of Development at The Terry Fox Foundation. “Terry Fox PROFYLE is an unprecedented Pan-Canadian precision medicine project that is showing promising results towards this goal. This initiative is possible thanks to the generosity of our donors like Scotiabank.”

Scotiabank has had a long relationship with the Terry Fox Foundation, dating back to Terry’s Marathon of Hope in 1980. Donations for the Terry Fox Run can be made at Scotiabank branches across Canada.

About Scotiabank

At Scotiabank, we aim to support organizations that are committed to helping young people reach their infinite potential. Young people are our future leaders and Scotiabank’s goal is to help ensure that they have the necessary skills and resources they need to support their success. Together with our employees, the Bank supports causes at a grassroots level. Recognized as a leader for our charitable donations and philanthropic activities, in 2018, Scotiabank contributed more than $80 million to help our communities around the world.

Scotiabank is Canada’s international bank and a leading financial services provider in the Americas. We are dedicated to helping our more than 25 million customers become better off through a broad range of advice, products and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. With a team of more than 100,000 employees and assets of over $1 trillion (as at July 31, 2019), Scotiabank trades on the Toronto Stock Exchange (TSX: BNS) and New York Stock Exchange (NYSE: BNS). For more information, please visit www.scotiabank.com and follow us on Twitter @ScotiabankViews.

SOURCE Scotiabank

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2019/18/c4373.html

For media enquiries only: Nicole Stevenson, Scotiabank, Nicolem.Stevenson@scotiabank.com, 437.227.3942 Copyright CNW Group 2019

Source: Canada Newswire (September 18, 2019 – 11:00 AM EDT)

News by QuoteMedia

www.quotemedia.com

Directed Energy Weapons: Star Wars Redux?

Directed Energy Weapons: Star Wars Redux?

Recent tests of prototype directed energy weapons (DEW) have made it clear that this form of weaponry has moved beyond just a theoretical concept. Although lasers were first demonstrated in 1960, advances in a wide range of science disciplines have allowed various forms of DEWs to be refined for both civilian and military uses. Weapons classified as DEWs include high energy lasers, electromagnetic railguns, and radio frequency weapons such as high-power microwaves and ultra-wideband weapons. So how close are we to the deployment of DEWs and what is driving the development of such weapons? Are the latest class of DEWs real or is this a Star Wars redux?

Offshore Wind Power Blows into the Energy Market

Offshore Wind Power Blows into the Energy Market

Offshore wind power is one of the most exciting and fastest-growing industries in renewable energy. Without any landmasses in the way, wind offshore blows strongly and consistently without interruption. Furthermore, offshore provides ample space and fewer restrictions for installing massive turbines, making offshore wind an attractive energy alternative to support the electric power needs of our populous coastal communities. Offshore wind turbines may achieve a higher output, but their remote ocean locations present costly challenges to installation. Additionally, a salty and humid environment at sea means much more maintenance than their land counterparts. However, improved efficiencies from advances in technology as well as government support have encouraged rapid growth of offshore wind energy installations in the past few years.

During 2018, the global capacity of offshore wind energy grew by 24% for a total of 23 gigawatts (GW) of annual energy production capacity, according to the Global Wind Energy Council (GWEC), an international trade association for the wind power industry. This explosive growth was partially fueled by the opening of the world’s biggest offshore wind farm off the coast of the United Kingdom. This wind farm can produce 659 megawatts (MW) annually, which is enough to power 590,000 homes. With this substantial addition, offshore wind power now provides nearly a tenth of the UK’s electricity. Indeed, the rapid acceleration of offshore wind energy installations inspires an optimistic outlook for this abundant renewable energy source.

Kelly Education Appoints New Education Sales Leader

Kelly Education Appoints New Education Sales Leader

Rick Lenkey joins
education talent provider that helps schools counter the teacher shortage

TROY, Mich., Sept. 17, 2019 (GLOBE NEWSWIRE) — Kelly Education, the nation’s first and largest educational talent provider, today announced that Rick Lenkey joined the company as vice president of education practice sales. In this role, Lenkey will lead the national sales organization in addressing the teacher shortage through quality workforce solutions. He brings extensive experience in education through his more than 20 years at McGraw-Hill Education, where he most recently served as vice president, national sales manager.

“We’re thrilled to welcome Rick and his dedication to partnering with educators to enrich student lives through education,” said Kelly Education Vice President and Managing Director Nicola Soares. “Each day, the teacher shortage continues to grow, impacting classrooms across the country. Rick’s leadership and expertise will enhance our ability to reach more school districts with our talent solutions that not only help counter the teacher shortage, but also support student achievement.”

“I’m excited to continue my career in education and particularly honored to be doing so with Kelly Education,” said Lenkey. “I’m looking forward to partnering with our schools to provide quality teaching staff in every classroom and more.”

About Kelly Education
At Kelly Education, we believe that education is a shared responsibility—and we’re dedicated to bringing the best educators to your classrooms. Operating as a specialty service of Kelly®, a global workforce solutions provider that’s always asking what’s next in the world of work, we’re proud to be the first comprehensive education talent management solution developed by a staffing company. Launched in 1997, Kelly Education partners with more than 7,000 public, private, and charter schools across 38 states. In addition, Kelly Education provides schools with quality substitute teacher staffing and management, as well as after-school program staffing, and the staffing of non-instructional positions such as custodians, cafeteria employees, administrative assistants, and school nurses. More than three million classrooms are filled by a Kelly Education substitute teacher each school year.

Media Contact:

Anna Schryver

Kelly Education

Senior Public Relations Manager

W: 248.469.0522 M: 608.225.5476

anna.schryver@kellyservices.com 

News Provided by GlobeNewswire via QuoteMedia

Will the Market Surpass All-Time Highs?

Will the Market Surpass All-Time Highs?

At the start of 2019, the stock market saw one of its strongest first halves on record. The S&P 500 rose more than 17%, making it the best start of the year for the index since 1997. The markets have continued to rise in the 3rd quarter, even with trade tensions accelerating and the thought of a recession looming. According to the latest ABC News poll, 60% of Americans think a recession is coming in the next 12 months, resulting from declining global economies. Although many believe we will enter into an economic contraction, economists are confident the market will continue to hold out.

How Will the Authorization of AB5 Impact Gig Economies?

How Will the Authorization of AB5 Impact Gig Economies?

On Wednesday, September 11th, the California state senate authorized legislation to reclassify certain groups of contractual gig economy workers as conventional company employees. The AB5 bill, which will be signed by Governor Gavin Newsom, will enact into law these changes limiting future gig economy potential. The gig economy provides freelancers and contract-based workers with an alternative to the traditional 9 to 5 job and supplemental income through app-based platforms. The AB5 bill targets many gig economy businesses and may affect ride-sharing companies such as Uber and Lyft, which have not been granted exemptions. Tony West, Uber Technologies lawyer stated, “Contrary to some of the rhetoric we’ve heard, AB5 does not automatically reclassify any ride-share drivers from independent contractors to employees. AB5 does not provide drivers with benefits. AB5 does not give drivers the right to organize. In fact, the bill currently says nothing about ride-share drivers.” Uber and Lyft help to supplement the gig economy with their worker base made of many independent contractors who do not receive company benefits.

ProMIS Neurosciences Executive Chairman Eugene Williams to Speak on Panel at Fall Investor Summit

ProMIS Neurosciences Executive Chairman Eugene Williams to Speak on Panel at Fall Investor Summit

TORONTO and CAMBRIDGE, MA, Sept. 16, 2019 /PRNewswire/ – ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced that Executive Chairman, Eugene Williams will participate on an executive panel at the Fall Investor Summit being held today at noon at the JW Marriot Essex House, 160 Central Park South, New York, NY.  

Mr. Williams will underline the importance of using novel blood-based biomarkers to significantly shorten drug development timelines and reduce costs for developing disease-modifying therapies specifically in neurodegenerative disease such as Alzheimer’s disease, Parkinson’s disease and ALS (amyotrophic lateral sclerosis).  

Participants include:

  • Moderator: John Vandermosten, Senior Biotech Analyst at Zacks Investment Research
  • Gene Williams, Executive Chairman, ProMIS Neurosciences
  • James Shanahan, Co-founder & VP of Business Development, SynDevRx
  • Jeff Galvin, CEO, American Gene Technologies
  • Scott Powell, CFO, VolitionRx
  • Alan Joslyn, CEO, Oragenics

About ProMIS Neurosciences
ProMIS Neurosciences, Inc. is a development stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). The Company’s proprietary target discovery platform is based on the use of two complementary thermodynamic, computational discovery engines – ProMIS and Collective Coordinates – to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique precision approach, the Company is developing novel antibody therapeutics for AD, ALS and PD. ProMIS is headquartered in Toronto, Ontario, with offices in Cambridge, Massachusetts. ProMIS is listed on the Toronto Stock Exchange under the symbol PMN, and on the OTCQB Venture Market under the symbol ARFXF.

To learn more, visit us at www.promisneurosciences.com, follow us on Twitter and LinkedIn and listen to the podcast, Saving Minds, at iTunes or Spotify.

The TSX has
not reviewed and does not accept responsibility for the adequacy or accuracy of
this release. This information release contains certain forward-looking
information. Such information involves known and unknown risks, uncertainties
and other factors that may cause actual results, performance or achievements to
be materially different from those implied by statements herein, and therefore
these statements should not be read as guarantees of future performance or
results. All forward-looking statements are based on the Company’s current
beliefs as well as assumptions made by and information currently available to
it as well as other factors. Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the date of this
press release. Due to risks and uncertainties, including the risks and
uncertainties identified by the Company in its public securities filings,
actual events may differ materially from current expectations. The Company
disclaims any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.

CisionView original content to download multimedia:http://www.prnewswire.com/news-releases/promis-neurosciences-executive-chairman-eugene-williams-to-speak-on-panel-at-fall-investor-summit-300918455.html

SOURCE ProMIS Neurosciences Inc.

News Provided by PR Newswire via QuoteMedia

Onconova Therapeutics Announces Presentation on Rigosertib at the RAS-Targeted Drug Discovery Summit

Onconova Therapeutics Announces Presentation on Rigosertib at the RAS-Targeted Drug Discovery Summit

NEWTOWN, Pa., Sept. 16, 2019 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on myelodysplastic syndromes (MDS), will present at the RAS-Targeted Drug Discovery Summit being held September 17-19 in Boston, Massachusetts.  Dr. Steven Fruchtman, President & CEO, will be presenting.  Also attending the conference will be Avi Oler, VP Corporate Development.

ABOUT RAS AND RIGOSERTIB:

There is a high frequency of Ras mutations in cancer that leads to the belief that mutations of the Ras Pathway provide a proliferative advantage and thus is involved in the pathogenesis of cancer.  As a result, targeting the Ras pathway has been the objective of scientific research for decades.  As published in the journal Cell in 2016, and now under investigation in a pivotal Phase 3 Trial, rigosertib targets the mutated RAS pathway by its interaction with Ras effector proteins containing the Ras Binding Domain.  The RAS-Targeted Drug Discovery Summit provides an opportunity to showcase the potential for rigosertib in MDS and in other RAS-driven cancers, such as KRAS-mutated lung cancer and colorectal cancer, and Ras- driven pediatric cancers as well. Onconova will review its INSPIRE Trial for which the Company anticipates reporting top-line data for second-line, higher-risk MDS patients in the first half of 2020 following full enrollment and 288 death events. Onconova’s representatives look forward to joining colleagues at the Summit to discuss advancements in rigosertib’s development and the progress the Company and others have made in targeting RAS.

DETAILS OF THE PRESENTATION:

Title:

Rigosertib: Targeting the Ras+ Pathway and Clinical Trials in MDS and Beyond

Date/Time:

Thursday, September 19th, 10:30 a.m.

Presenter:

Steven M. Fruchtman, M.D.

About Onconova Therapeutics, Inc. 
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company discovering and developing novel small molecule drug candidates to treat cancer, with a focus on Myelodysplastic Syndromes (MDS).  Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.  Onconova has three product candidates in the clinical stage and several pre-clinical programs.  Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.  For more information, please visit 
http://www.onconova.com

About Myelodysplastic Syndromes 
Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. It is frequently associated with the presence of blasts or leukemic cells in the marrow.  This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.  Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anemia).  Patients with higher-risk MDS may progress to the development of acute leukemia. 

About Rigosertib 
Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.  A key publication demonstrated rigosertib’s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: “A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.” Cell 165, 643). Onconova is currently in the clinic with oral and IV rigosertib, including single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line higher-risk MDS patients (Phase 2).  Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 

About the INSPIRE Phase 3 Clinical Trial 
The 
INternational Study of Phase 3 IRigosErtib, or 
INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.  INSPIRE is a global multi-center, randomized controlled study to assess the efficacy and safety of IV rigosertib in HR-MDS patients who had progressed on, failed to respond to, or relapsed after previous treatment with an HMA within nine cycles over the course of one year after initiation of HMA treatment.  This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines.  An interim analysis in early 2018 demonstrated a promising survival signal in the intent-to-treat population as reviewed by the Independent Data Monitoring Committee.  The Committee recommended that the trial continue with an expansion in enrollment to 360 patients based on a pre-planned sample size re-estimation.  Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.  The primary endpoint of INSPIRE is overall survival. Full details of the INSPIRE trial, such as inclusion and exclusion criteria, as well as secondary endpoints, can be found on clinicaltrials.gov (NCT02562443). 

About IV Rigosertib 
The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with higher-risk MDS (HR-MDS), after failure of hypomethylating agent, or HMA, therapy. 

About Oral Rigosertib 
The oral form of rigosertib was developed to provide more convenient dosing for use where the duration of treatment may extend to multiple years. This dosage form may also support combination therapy modalities.? To date, over 400 patients have been studied with the oral formulation of rigosertib.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.? A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology Annual Meeting in December 2018. ?A new pivotal Phase 3 study design is under discussion with the FDA.

Forward-Looking Statements 
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and involve risks and uncertainties. These statements relate to Onconova expectations regarding the INSPIRE Trial and Onconova’s other development plans. Onconova has attempted to identify forward-looking statements by terminology including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes. Although Onconova believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements.  These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including Onconova’s ability to continue as a going concern, the need for additional financing, the success and timing of Onconova’s clinical trials and regulatory approval of protocols, our collaborations, and those discussed under the heading “Risk Factors” in Onconova’s most recent Annual Report on Form 10-K and quarterly reports on Form 10-Q.  Any forward-looking statements contained in this release speak only as of its date.  Onconova undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events. 

General Contact 

Avi Oler 
Onconova Therapeutics, Inc.  
267-759-3680 

ir@onconova.us  
http://www.onconova.com/contact/ 

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Industry Report – Minerals – Insights from the Precious Metals Summit

Monday, September 16, 2019

Minerals Industry Report

Insights from the Precious Metals Summit

Mark Reichman, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to end of report for Analyst Certification & Disclosures

  • Another successful conference. The Precious Metals Summit was held September 10-13 at the Beaver Creek Resort in Colorado. Nearly 1,100 persons attended with over 180 companies and 262 buy-side firms represented. Attendance surpassed last year’s participation. While the Precious Metals Summit leans toward junior mining companies, this analyst “struck-up” conversations with more than a few business development executives from larger players who were there to scout opportunities.
  • Optimistic precious metals outlook. With gold and silver futures prices up 5% and 14.5%, respectively, since the end of June, the mood was cautiously optimistic. While management teams expect metals prices to be volatile, the consensus among participants we spoke with was that gold and silver still have room to move higher. While major producers seem to have garnered the most investor attention during the recent rally, generalist investor interest in the sector is returning. With sustained or rising prices, greater interest will likely filter down to the junior and intermediates.
  • Emerging jurisdictions. We had several conversations with industry participants concerning mining jurisdictions that are increasingly becoming more attractive to outside investors due to changes in the political, regulatory and commerce climate.
  • Royalty companies well-represented. While the equity capital markets remain challenging for micro and small-cap companies, royalty and streaming businesses remain an active source of capital. Royalty companies were well-represented at the conference. Beyond providing a source of capital for mining interests, royalty companies have increasingly become popular with investors due to lower direct operating risk and the ability to diversify among various mining jurisdictions, metals and operators. Importantly, investors appreciate the potential for growing dividends.

Precious Metals Summit Beaver Creek 2019

Noble Capital Markets was represented at the 2019 Precious Metals Summit held at the Beaver Creek Resort in Colorado. The conference provided an opportunity to meet with management teams in one-on-one settings and benefit from the conference programming which included panel discussions, interviews and presentations. An investor discussion featuring Neil Gregson (J.P. Morgan Asset Management) and Neil Adshead (Sprott Inc.) covered, among other things, the highs and lows of precious metals investing. A fireside chat between John Hathaway (Tocqueville Asset Management) and David Rosenberg (Gluskin Sheff) centered on the macroeconomic environment.

Outlook for the Remainder of 2019 and into 2020

During the third quarter through September 13, the VanEck Gold Miners ETF appreciated 4.2%, while the VanEck Vectors Junior Gold Miners ETF (GDXJ) appreciated 3.7%. Both peaked on September 4 and then declined through the remainder of September. Year-to-date, they are up 26.3% and 20.0%, respectively. Comparatively, the S&P 500 Index appreciated 2.8% and 20.0% during the same periods. During the third quarter, the futures price of gold and silver increased 5.2% and 14.5%, respectively. Futures suggest gold above $1,500 an ounce in 2020, with silver prices in the mid-$17 range. The gold/silver ratio was 85.3x as of September 13; down from 92.0x at the close of the second quarter and we still maintain our view that silver remains undervalued relative to gold and thus could represent greater long-term price appreciation potential.

A few of the key contributors to gold’s strength during the third quarter include a rather dovish posture from the Federal Reserve Open Markets Committee which lowered the target range for the federal funds rate by 25 basis points to 2.0% to 2.25% at its June meeting and the expectation that the Fed could further lower the target range. Accommodation by the Fed could send the dollar lower which would be supportive of precious metals although the fact that other central banks are lowering rates could mute or offset the impact on a relative basis versus other currencies. Second, trade concerns, particularly with China, helped sustain gold’s rally along with increasing geopolitical tensions, most notably with Iran.

In our view, monetary policy, geopolitical risk and trade, along with concerns about global economic growth and recession fears in the U.S., will most likely drive movements in gold for the remainder of the year. Underscoring concerns about economic growth and a more dovish posture by the U.S. Federal Reserve and other Central Banks may strengthen gold’s appeal. This is especially true given that real interest rates are negative in some countries. The possibility that more debt will yield negative real rates has implications for the values of global currency thus promoting precious metals’ role as a store of value.

According to the World Gold Council, gold demand was up 8% year-over year in the second quarter to 1,123 tonnes. For the first six months, demand increased to a three-year high of 2,181.7 tonnes due, in part, to demand from central banks. Second quarter central bank net purchases rose 47% on a year-over-year basis to 224.4 tonnes while during the first six months, total net purchases increased 57% on a year-over-year basis.

In our view, mining stocks are an attractive way to gain exposure to metals given their leverage to strengthening metals prices. Precious metals stocks may provide a hedge against volatility in the equity markets and offer diversification benefits.

Precious Metals Summit Scouting Report

The junior mining sector offers a source of projects, whether through joint ventures, outright sale or alternative arrangements, to intermediate and major production companies who have increasingly emphasized project identification and analytics. A common refrain in the industry is that one million ounces of reserves and resources is the minimum threshold to be of interest to mid-tier producers, while the minimum threshold for senior producers is three to five million ounces. Any thing lower is not considered to be a good use of time since they are seeking to replace at least a year’s worth of production and are looking for projects that move the needle.

During the conference, we spoke with several representatives of senior producers that were in attendance, not to present or host one-on-one meetings, but to network with the managements of junior mining companies and scout promising projects. We heard time and again that good projects will get financed and others will have difficulty getting financed. While many of these representatives were responsible for scouting projects in specific geographic regions, the approach to evaluating projects was consistent. Resource potential, quality of resources, infrastructure access and mining jurisdiction were just a few of the items mentioned.

First Mover Advantage

During the conference, we spoke with managements whose companies operate across the globe. Investors in mining stocks pay close attention to the Fraser Institute Annual Survey of Mining Companies which rates mining jurisdictions globally based on their geologic attractiveness for minerals and metals and the extent to which government policies encourage or discourage exploration and investment. In the 2018 survey, the state of Nevada ranked as the most attractive jurisdiction in the world for mining investment, followed by Western Australia, Saskatchewan and Quebec. We pay attention to the survey to analyze which jurisdictions are moving up or down in rank. There are mineral rich jurisdictions in the world that rank favorably in geologic attractiveness for minerals and metals although government policies discourage or deter exploration and investment. We think investors could profit from paying attention to those that are experiencing structural improvement because first movers could reap the rewards of getting in early.

By way of example, we met with several mining companies operating in Ecuador, including Aurania Resources (TSX.V: ARU, Outperform), Lumina Gold (TSX.V: LUM, Not Rated) , Salazar Resources (TSX.V: SRL, Not Rated), SolGold (TSX: SOLG, Not Rated) and Adventus (TSX.V: ADZN, Not Rated). The management teams pointed to meaningful policy and regulatory changes that are supportive of the mining industry. Ecuador has received attention lately because the government has invested in infrastructure and enacted policies and regulations to encourage responsible mining as a means of diversifying and growing its economy. Although it still ranks relatively low according to the Fraser Institute Investment Attractiveness Index, its percentile ranking has improved each year from 2014 to 2018. While Ecuador still has work to do and it may take a while longer to further enhance its ranking, its efforts seem to be paying dividends as it has attracted the attention of major players such as Newcrest Mining Limited (ASX: NCM, Not Rated) and Lundin Gold (TSX: LUG, Not Rated).

Emerging Royalty Companies

A royalty is a right to receive a percentage or other measure of mineral production from a mining company. There are various types of royalties. A streaming agreement is a financial transaction where a metals producer sells forward the right to a percentage of its future life of mine production at a set price in exchange for a tax-deferred upfront payment. Royalty or streaming companies provide capital to help fund the development of mines in return for a life-of-mine royalty on production or under a streaming agreement. A few well-known streaming and royalty companies include Franco Nevada (TSX: FNV, Not Rated), Royal Gold (Nasdaq: RGLD, Not Rated) and Wheaton Precious Metals (TSX: WPM.CA, Not Rated). Because of growing investor interest in royalty and streaming companies, the universe of royalty and streaming companies has grown. During the conference, we met with executives of several, including EMX Royalty Corp (TSX.V: EMX, Not Rated), Maverix Metals (TSX: MMX, Not Rated), Ely Gold Royalties (TSX.V: ELY, Not Rated) and Sailfish Royalty Corp. (TSX.V: FISH, Not Rated). Some develop projects, sell it and retain a royalty. Others purchase and sell portfolios of royalties. Some pursue a combination of strategies. Beyond providing a source of capital for mining interests, royalty companies have increasingly become popular with investors due to lower direct operating risk and the ability to diversify among various mining jurisdictions. In addition, royalty companies often have lower operating cost structures due to relatively fewer employees. Importantly, investors appreciate the potential for growing dividends. During periods when capital markets are challenging, royalty and streaming companies are poised to benefit from providing alternative sources of funding. Given their attractiveness to investors, we believe the universe of royalty businesses will continue to grow. While it may become more competitive, smaller royalty companies may be able to pick up market share as producers seek to diversify their sources of funding and promote competition.

Conclusions

In our opinion, the requisite conditions appear to be in place to sustain the recent strength in precious metals prices. While major producers appear to have captured the most investor attention during the recent rally in silver and gold prices, we expect junior mining companies to catch up if metals prices continue to hold and/or increase. Once the industry is confident in a stable or rising commodity price outlook, we expect M&A activity to accelerate. Because we believe the odds favor the recent move in precious metals prices to hold or strengthen, now may be a good time to begin accumulating shares in select mining equities to increase exposure to precious metals and enhance portfolio diversity. Among the junior, intermediate and major mining names in our universe, we believe the following merit investor consideration and are rated Outperform: Aurania Resources Ltd. (TSX.V: ARU), Coeur Mining (NYSE: CDE), Great Panther Mining Limited (NYSE American: GPL), and Sierra Metals Inc. (NYSE American: SMTS).

GENERAL DISCLAIMERS

All statements or opinions contained herein that include the words “we”, “us”, or “our” are solely the responsibility of Noble Capital Markets, Inc.(“Noble”) and do not necessarily reflect statements or opinions expressed by any person or party affiliated with the company mentioned in this report. Any opinions expressed herein are subject to change without notice. All information provided herein is based on public and non-public information believed to be accurate and reliable, but is not necessarily complete and cannot be guaranteed. No judgment is hereby expressed or should be implied as to the suitability of any security described herein for any specific investor or any specific investment portfolio. The decision to undertake any investment regarding the security mentioned herein should be made by each reader of this publication based on its own appraisal of the implications and risks of such decision.

This publication is intended for information purposes only and shall not constitute an offer to buy/sell or the solicitation of an offer to buy/sell any security mentioned in this report, nor shall there be any sale of the security herein in any state or domicile in which said offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or domicile. This publication and all information, comments, statements or opinions contained or expressed herein are applicable only as of the date of this publication and subject to change without prior notice. Past performance is not indicative of future results. Noble accepts no liability for loss arising from the use of the material in this report, except that this exclusion of liability does not apply to the extent that such liability arises under specific statutes or regulations applicable to Noble. This report is not to be relied upon as a substitute for the exercising of independent judgement. Noble may have published, and may in the future publish, other research reports that are inconsistent with, and reach different conclusions from, the information provided in this report. Noble is under no obligation to bring to the attention of any recipient of this report, any past or future reports. Investors should only consider this report as single factor in making an investment decision.

IMPORTANT DISCLOSURES

This publication is confidential for the information of the addressee only and may not be reproduced in whole or in part, copies circulated, or discussed to another party, without the written consent of Noble Capital Markets, Inc. (“Noble”). Noble seeks to update its research as appropriate, but may be unable to do so based upon various regulatory constraints. Research reports are not published at regular intervals; publication times and dates are based upon the analyst’s judgement. Noble professionals including traders, salespeople and investment bankers may provide written or oral market commentary, or discuss trading strategies to Noble clients and the Noble proprietary trading desk that reflect opinions that are contrary to the opinions expressed in this research report.
The majority of companies that Noble follows are emerging growth companies. Securities in these companies involve a higher degree of risk and more volatility than the securities of more established companies. The securities discussed in Noble research reports may not be suitable for some investors and as such, investors must take extra care and make their own determination of the appropriateness of an investment based upon risk tolerance, investment objectives and financial status.

Company Specific Disclosures

The following disclosures relate to relationships between Noble and the company (the “Company”) covered by the Noble Research Division and referred to in this research report.
Noble is not a market maker in any of the companies mentioned in this report. Noble intends to seek compensation for investment banking services and non-investment banking services (securities and non-securities related) with any or all of the companies mentioned in this report within the next 3 months

ANALYST CREDENTIALS, PROFESSIONAL DESIGNATIONS, AND EXPERIENCE

Senior Equity Analyst focusing on Basic Materials & Mining. 20 years of experience in equity research. BA in Business Administration from Westminster College. MBA with a Finance concentration from the University of Missouri. MA in International Affairs from Washington University in St. Louis.
Named WSJ ‘Best on the Street’ Analyst and Forbes/StarMine’s “Best Brokerage Analyst.”
FINRA licenses 7, 24, 63, 87

WARNING

This report is intended to provide general securities advice, and does not purport to make any recommendation that any securities transaction is appropriate for any recipient particular investment objectives, financial situation or particular needs. Prior to making any investment decision, recipients should assess, or seek advice from their advisors, on whether any relevant part of this report is appropriate to their individual circumstances. If a recipient was referred to Noble Capital Markets, Inc. by an investment advisor, that advisor may receive a benefit in respect of
transactions effected on the recipients behalf, details of which will be available on request in regard to a transaction that involves a personalized securities recommendation. Additional risks associated with the security mentioned in this report that might impede achievement of the target can be found in its initial report issued by Noble Capital Markets, Inc.. This report may not be reproduced, distributed or published for any purpose unless authorized by Noble Capital Markets, Inc..

RESEARCH ANALYST CERTIFICATION

Independence Of View
All views expressed in this report accurately reflect my personal views about the subject securities or issuers.

Receipt of Compensation
No part of my compensation was, is, or will be directly or indirectly related to any specific recommendations or views expressed in the public
appearance and/or research report.

Ownership and Material Conflicts of Interest
Neither I nor anybody in my household has a financial interest in the securities of the subject company or any other company mentioned in this report.

NOBLE RATINGS DEFINITIONS % OF SECURITIES COVERED % IB CLIENTS
Outperform: potential return is >15% above the current price 86% 25%
Market Perform: potential return is -15% to 15% of the current price 14% 2%
Underperform: potential return is >15% below the current price 0% 0%

NOTE: On August 20, 2018, Noble Capital Markets, Inc. changed the terminology of its ratings (as shown above) from “Buy” to “Outperform”, from “Hold” to “Market Perform” and from “Sell” to “Underperform.” The percentage relationships, as compared to current price (definitions), have remained the same. Additional information is available upon request. Any recipient of this report that wishes further information regarding the subject company or the disclosure information mentioned herein, should contact Noble Capital Markets, Inc. by mail or phone.

Noble Capital Markets, Inc.
225 NE Mizner Blvd. Suite 150
Boca Raton, FL 33432
561-994-1191

Noble Capital Markets, Inc. is a FINRA (Financial Industry Regulatory Authority) registered broker/dealer.
Noble Capital Markets, Inc. is an MSRB (Municipal Securities Rulemaking Board) registered broker/dealer.
Member – SIPC (Securities Investor Protection Corporation)
Report ID: 11091

Eagle Bulk Shipping Inc. Takes Delivery of MV Sydney Eagle


Eagle Bulk Shipping Inc. Takes Delivery of M/V Sydney Eagle

STAMFORD, Conn., Sept. 16, 2019 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle Bulk” or the “Company”), one of the world’s largest owner-operators within the Supramax / Ultramax segment, today announced that is has taken delivery of the second of six Ultramax drybulk vessels, it has recently agreed to acquire.

The ship, which has been renamed the M/V Sydney Eagle, is a 2015-built, high specification scrubber-fitted SDARI-64 Ultramax vessel built at Jiangsu New Hantong Ship Heavy Industry Co., Ltd.

Proforma for the four remaining acquisition vessels, which have yet to be delivered, the Company’s fleet will total 50 ships, including 20 Ultramax drybulk vessels acquired over the last 36 months.

About Eagle Bulk Shipping Inc.

Eagle Bulk Shipping Inc. (“Eagle” or the “Company”) is a US-based fully integrated shipowner-operator providing global transportation solutions to a diverse group of customers including miners, producers, traders, and end users. Headquartered in Stamford, Connecticut, with offices in Singapore and Copenhagen, Eagle focuses exclusively on the versatile mid-size drybulk vessel segment and owns one of the largest fleets of Supramax / Ultramax vessels in the world. The Company performs all management services in-house (including: strategic, commercial, operational, technical, and administrative) and employs an active management approach to fleet trading with the objective of optimizing revenue performance and maximizing earnings on a risk-managed basis. For further information, please visit our website: www.eagleships.com.

Company Contact:
Frank De Costanzo
Chief Financial Officer
Eagle Bulk Shipping, Inc.
Tel. +1 203-276-8100

Media Contact:
Rose & Company
Tel. +1 212-359-2228

Primary Logo

 

Source: GlobeNewswire (September 16, 2019 – 8:30 AM EDT)

News by QuoteMedia
www.quotemedia.com